VanEck ChiNext Innovators ETF

CNXT
ETF Ticker

-0.02%

+0.94%

NYSE Arca Exchange

Equity

China

Mid & Small Cap

The VanEck ChiNext Innovators ETF, CNXT_US, is listed on the NYSE Arca Exchange and tracks the ChiNext index. The fund provides exposure to China, Mid & Small Cap Equity and has assets under management of $114.0m (as of Aug 31, 2026). The ETF trades in USD and was listed on the exchange on Jul 23, 2014. It has a net expense ratio of 65bps. (All data in USD as of Oct 9, 2026 unless stated.)

The underlying ChiNext Index provides free-float market cap exposure to companies listed on the ChiNext Market of the Shenzhen Stock Exchange. The universe includes all ChiNext A-shares that are not under special treatment, have been listed for at least six months unless they rank among the top 1% of the Shenzhen market by total market cap, and pass checks on financial reporting, operations and price behavior. At each semiannual review, stocks are ranked by six-month trading value, the bottom decile is removed and those with CNI ESG ratings below B are excluded. Remaining stocks are ranked by six-month average total market cap and the top 100 are selected, with at most 10 new names per review, a 70/130% entry/retention buffer and a 5% reserve list. Constituents are weighted by free-float market cap with an individual cap of 20%, and the index is rebalanced and reconstituted each June and December.

ETF Details

Key Facts

Issuer:
VanEck
AUM:
$114.0m (as of Aug 31, 2026)
Net Expense Ratio:
65 bps
Inception Date:
Jul 23, 2014
Index:
ChiNext Index
Dividend Frequency:
Annually

Trading

Ticker:
CNXT
Exchange:
NYSE Arca Exchange
ISIN:
US92189F6271
Trading Currency:
USD
Domicile:
United States

Classification & Risk

Asset Class:
Equity
Asset Region:
China
Theme:
Mid & Small Cap
Economic Development:
Emerging Markets
1 Year Volatility:
35.36%
3 Year Volatility:
41.26%
5 Year Volatility:
36.30%

Performance

TTM Dividend Yield:
0.18% (verify with issuer)
1 Month Performance:
-8.83%
3 Month Performance:
-23.88%
6 Month Performance:
-6.46%
1 Year Performance:
0.94%
3 Year Performance:
73.29%
5 Year Performance:
-6.26%
Investment Proposition

VanEck ChiNext Innovators ETF (CNXT) provides targeted exposure to growth-oriented China A-shares listed on Shenzhen’s innovation board, emphasizing companies tied to technology, advanced manufacturing, healthcare, and consumer upgrades. The strategy seeks to replicate a rules-based universe of the largest and most liquid listings on that market segment, resulting in a portfolio that naturally tilts toward higher-beta, research-intensive businesses with reinvestment needs. Return drivers center on domestic demand, productivity gains, and capital formation within China’s new-economy sectors, while risks include policy shifts, regulatory interventions, and currency moves that can amplify volatility. Style characteristics may skew toward growth and smaller to mid-sized franchises, creating sensitivity to risk appetite and funding conditions; conversely, periods of improving earnings breadth and pro-innovation policy tone can be supportive. Use cases include a satellite growth sleeve, a thematic mandate focused on Chinese innovation, or a factor completion tool to increase exposure to quality-growth cyclicality within emerging markets. Investors most likely to consider CNXT are high-conviction allocators pursuing long-term growth or global equity strategists seeking a dedicated China innovation sleeve. Key risk to monitor: concentration in innovation-heavy industries can heighten drawdown severity in adverse regulatory or liquidity regimes.

ETF Analytics

Fund Discovery

4 Suggestions